
|Videos|July 27, 2022
Dr. Alexis Rompré-Brodeur on germline testing in renal cell carcinoma
Author(s)Urology Times staff
Advertisement
Alexis Rompré-Brodeur, MD, a urologic oncologist at McGill University discusses germline testing in patients with renal cell carcinoma. Rompré-Brodeur presented the study, “Germline testing in renal cell carcinoma: can enrichment features help predict germline alterations?” at the 2022 AUA Annual Meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
ARASEC: Clinical Implications and the Role of Multidisciplinary Care
2
FDA grants tentative approval to generic enzalutamide tablets
3
2026 AUA/SUO Advanced Prostate Cancer Guideline: Key updates and clinical FAQs
4
Atish Choudhury, MD, PhD, highlights phase 2 data on treatment interruption in mHSPC
5












